Charlotte, North Carolina, Bristol, Tennessee and London, Ontario, Canada – (February 20, 2004) – SJ Strategic Investments LLC (“SJ”) announced today the purchase of over 4 million shares of Stellar International, Inc. (Stellar). Bourne Partners served as an advisor to SJ for the investment in Stellar, a Canadian pharmaceutical developer and marketer of high quality, cost-effective products for select health care markets. As a result of this transaction, Stellar has agreed to issue 4,088,794 common shares to SJ for U.S.$ 0.74 per common share, which represents 19.9% of the issued and outstanding Stellar common shares, on a non-diluted basis (including the Stellar common shares issued in the private placement). The aggregate proceeds of the private placement are U.S. $3,025,708. The Stellar common shares issued in the private placement are subject to a four-month hold period.
